Peer Review channel feed

Af­ter huge mega-round, CStone poach­es Gold­man's Richard Yeh as CFO; Both Hoop­er and Harp­er ex­it Am­gen's re­volv­ing door

7 years ago

An­tho­ny Quinn ce­ments Ae­glea CEO spot; Hu­man Longevi­ty bumps David Karow up to the top

7 years ago

George Golumbeski's first stop out of Cel­gene: Grail; Roivant taps Genen­tech vet Myr­tle Pot­ter for op­er­a­tions role

7 years ago

Ac­celeron poach­es ex-Abl­ynx CMO Robert Zeldin; Deb­o­rah Dun­sire leaves for Lund­beck­'s top job af­ter XTu­it im­plo­sion

8 years ago

An­drew Rit­ter gath­ers the reins as his com­pa­ny preps PhI­II; Sol­id Bio co-founder Gi­lad Hay­eem re­tires

8 years ago

In high-lev­el reshuf­fle, Roche gives James Sabry the glob­al reins on deal-mak­ing — over­see­ing pRED and gRED

8 years ago
People

Aim­mune signs Jayson Dal­las on to suc­ceed re­tir­ing CEO; Ed­uar­do Bra­vo leaves TiGenix in fi­nal chap­ter of Take­da buy­out

8 years ago

Ru­bius snaps up No­var­tis vet Pablo Cagnoni as CEO; MiMedx dumps two ex­ecs fol­low­ing in­ter­nal in­ves­ti­ga­tion

8 years ago

Top re­search ex­ecs from Te­va, Al­ler­gan re­cruit­ed to help lead Ax­o­vant out of the R&D waste­land

8 years ago
People
R&D

Ex-Gilead R&D chief Bischof­berg­er starts over as CEO of Kro­nos Bio; Sue Ma­ho­ny steps down from Lil­ly On­col­o­gy

8 years ago

Roivant brings Pfiz­er vets Azoulay, Gul­fo in­to its C-suite; Aileron CEO Joseph Yanchik is out

8 years ago

Jose Car­los 'JC' Gutiér­rez-Ramos hits the ex­it at Syn­log­ic; Rich Hey­man pass­es Oric reins to ex-Igny­ta CFO

8 years ago

C4 Ther­a­peu­tics bumps An­drew Phillips to CEO; Milind Desh­pande ex­its Achillion; Leena Gand­hi to head up I/O at Eli Lil­ly

8 years ago

Ex-As­traZeneca ex­ec Lisa An­son to lead do-over at Redx; Ad­vax­is shakes up C-suite

8 years ago

John Or­win tapped to lead Atre­ca; John Tsai takes Vas Narasimhan's old role at No­var­tis; Hal Bar­ron nabs Genen­tech's Kevin Sin

8 years ago

Dal­cor taps new CEO Fouzia Laghris­si-Th­ode as piv­otal PhI­II looms; Kel­ly Mar­tin set­tles in at No­van; Ed­ward Stew­art takes over Com­mense

8 years ago

Re­tire? Bill Chin’s tried it three times, and he’d rather be work­ing at Fre­quen­cy Ther­a­peu­tics

8 years ago
People

Top As­traZeneca I/O vet Robert Ian­none jumps to Im­munomedics as R&D chief as BLA looms

8 years ago
People

Abeona ap­points new chief as Tim­o­thy Miller moves to CSO; Max­ine Gowen pass­es Treve­na ba­ton to Car­rie Bour­dow; Scott Smith out in Cel­gene re­vamp

8 years ago

Hir­ing? How End­points can help your com­pa­ny fill open po­si­tions with our tal­ent­ed read­ers

8 years ago
Publisher's note

Am­gen vet Marc de Garidel takes the helm at Cor­vidia; Pe­ter Green­leaf lands next CEO job at Cere­cor; Ed­ward Gu­daitis tapped to lead Acerus

8 years ago

Di­rec­tor of di­ver­si­ty and in­clu­sion ar­rives at Mass­Bio; Jerome Jab­bour takes the helm at Mati­nas; Ex-Eli Lil­ly CFO be­comes pres­i­dent of PBM busi­ness

8 years ago

Long­time R&D chief Bischof­berg­er leaves Gilead; No­var­tis op­er­a­tions chief heads out; Astel­las taps Bar­ret­to-Ko to run Amer­i­c­as op­er­a­tions

8 years ago

Out­sourc­ing vet­er­an Jamie Mac­don­ald takes the helm at Parex­el; CSO Rosana Kapeller ex­its Nim­bus

8 years ago
First page Previous page 13141516171819 Next page Last page
A service from the Financial Times